Warning that spies have “traded trench coats for lab coats,” analysts from Canada’s spy agency have begun giving briefs to Canadian universities, medical research institutes, pharmaceutical companies and others involved in the pandemic response on emerging national security threats.
Topic: emerging technologies
The WHO has launched a global registry to track research on human genome editing—the first concrete recommendation of an advisory committee charged with determining what an effective oversight and governance framework should look like in the CRISPR era. At the same time, medical and scientific societies in other nations are grappling with the unprecedented ethical and scientific implications of altering the human genome in future generations.
Seed-stage companies are bolstering Canada’s position as a global leader in quantum science and technology. The question of how to maintain and grow that advantage—built through sustained investment in quantum research and development—has never been more urgent and is preoccupying academics, policymakers and innovators across the country.
Ottawa should admit it has an innovation performance problem and adopt solutions that include industrial sector strategies, innovation targets and an innovation strategy that is an export strategy.